Members |
targetComponentId |
Deficiency of pyruvic dehydrogenase |
Pyruvate dehydrogenase complex deficiency |
Deficient knowledge of traditional therapy |
Deficient knowledge of complementary therapy |
Defluvibacter lusatiensis |
Aquamicrobium lusatiense (organism) |
Deformity due to adhesions |
Deformity |
Degenerative colloid atrophy |
Colloid milium (disorder) |
Degenerative joint disease of thigh |
Disorder of lower limb |
Degenerative lesion of articular cartilage of knee |
Degenerative disorder of articular cartilage of knee (disorder) |
Degenerative lesion of articular cartilage of knee |
Degenerative disorder of articular cartilage of knee (disorder) |
Degree elevation of head of bed for tube feeding of patient |
The angle, expressed in degrees, that the head of the bed is raised during delivery of enteral nutrition feeding. |
Dehydrogenase |
Dehydrogenase |
Delay in sexual development and puberty, NEC |
Delay in sexual development AND/OR puberty |
Delayed |
Delayed priority |
Delayed allergy to red meat |
An allergic condition in which people are allergic to alpha-gal, a sugar found in the tissues of all mammals except humans and other primates. When people who are allergic to alpha-gal eat beef, pork, lamb, or meat from other mammals, they have an allergic reaction that causes a range of symptoms, including a rash, nausea, vomiting, and diarrhoea. In some cases, there may be an immediate life-threatening anaphylactic reaction. Many report that allergic symptoms to meat began after a series of tick bites. The tick species most often implicated in meat allergy have been Amblyomma americanum (the lone star tick) in the eastern, southeastern, and south-central parts of the United States and other species (Ixodes ricinus, Ixodes holocyclus, Amblyomma cajennense, Amblyomma sculptum, and Haemaphysalis longicornis) in other parts of the world. |
Delayed conjugation causing neonatal jaundice NOS |
Neonatal jaundice due to delayed conjugation (finding) |
Delayed delivery second twin with antenatal problem |
Delayed delivery of second twin |
Delayed healing of surgical wound |
Delayed healing of surgical wound (finding) |
Delayed healing surgical wound |
Delayed healing of surgical wound (finding) |
Delayed healing surgical wound |
Delayed healing of surgical wound (finding) |
Delayed or excessive hemorrhage NOS following abortive pregnancy |
Disorder following induced termination of pregnancy (disorder) |
Delayed or excessive hemorrhage NOS following abortive pregnancy |
Disorder following induced termination of pregnancy (disorder) |
Delayed primary suture of skin NEC |
Delayed primary suture of skin |
Deletion of long arm of chromosome 17 |
A partial deletion of the long arm of chromosome 17 characterized by hypotonia, growth delay, severe global developmental delay, microcephaly, seizures, congenital heart anomalies, hand and foot anomalies (syndactyly, symphalangism) and dysmorphic facial features, including round face, hypertelorism, upslanting palpebral fissures, and micrognathia. Reported deletions involve regions 17q21-q24. |
Delirium caused by substance or medication |
Delirium |
Delivery booking - place NOS |
Delivery place booking (procedure) |
Delivery booking - place NOS |
Delivery place booked |
Delivery booking - stay NOS |
Delivery booking - length of stay |
Delivery booking - stay NOS |
Delivery length of stay booking (procedure) |
Delivery risk |
At increased risk for complication during labour and delivery |
Delta hepatitis viral agent |
Hepatitis D virus |
Delta-9-tetrahydrocannabinol 27mg/mL/cannabinol 25mg/mL buccal spray |
Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
Demented relative |
Family history of dementia (situation) |
Dementia following injury caused by exposure to ionizing radiation |
Dementia caused by ionizing radiation |
Demineralization of enamel of teeth |
Incipient enamel caries |
Demonstrates knowledge of traditional therapy |
Demonstrates knowledge of complementary therapy (finding) |
Dendritic cell sarcoma, no International Classification of Diseases for Oncology subtype |
Dendritic cell sarcoma |
Dendroaspis viridis |
Dendroaspis angusticeps (organism) |
Dendrocygnini |
Subfamily Dendrocygninae (organism) |
Dental diseases and conditions NOS |
Disorder of teeth AND/OR supporting structures (disorder) |
Dental diseases and conditions NOS |
Disorder of teeth AND/OR supporting structures (disorder) |
Dental practitioner NOS |
Dentist |
Dental practitioner NOS |
Dentist |
Denver shunt |
Peritoneovenous shunt |
Denver shunt patency test |
Peritoneovenous shunt patency test |
Deoxycortisol |
Cortodoxone |
Deoxycortisone |
Cortodoxone |
Deoxyribonucleic acid of Aeromonas salmonicida |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of African swine fever virus |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Alcelaphine herpesvirus 1 |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Avipoxvirus |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Caprine arthritis encephalitis virus |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Capripoxvirus |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Cowdria ruminantium |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Equine herpesvirus 1 |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Equine herpesvirus 4 |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Feline herpesvirus 1 |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Lumpy skin disease virus |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Marek's disease virus |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Mycoplasma agalactiae |
Mycoplasma DNA |
Deoxyribonucleic acid of Mycoplasma gallisepticum |
Mycoplasma DNA |
Deoxyribonucleic acid of Ovine herpesvirus 2 |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Ovine progressive pneumonia virus |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Pseudorabies virus |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Taylorella equigenitalis |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Theileria mutans |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Theileria parva |
Deoxyribonucleic acid of microorganism (substance) |
Deoxyribonucleic acid of Trypanosoma evansi |
Deoxyribonucleic acid of microorganism (substance) |
Department of Health and Social Security (DHSS) medical examination NOS |
Specialized medical examination |
Dependence caused by dissociative substance |
Hallucinogen dependence |
Dependence on unknown drug |
The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months. |
Dependent territories of United Kingdom of Great Britain and Northern Ireland |
British Overseas Territories (geographic location) |
Depo-provera injection given |
Injection of medroxyprogesterone acetate (procedure) |
Deposition of sodium urate crystals with inflammatory morphology |
Deposition of monosodium urate crystals with inflammatory morphology |
Depot contraceptive NOS |
Depot contraceptive status |
Depot contraceptive NOS |
Depot contraceptive status |
Depot contraceptive given |
Administration of depot contraceptive (procedure) |
Depression NOS |
Depressive disorder |
Depression NOS |
Depressive disorder |
Depressor anguli oris flap |
Depressor anguli oris myocutaneous flap |
Depth of CVS examination NOS |
Cardiovascular examination finding |
Depth of CVS examination NOS |
Depth of CVS examination |
Depth of GIT examination NOS |
Gastrointestinal test observable |
Depth of GU examination NOS |
Genitourinary examination finding |
Depth of GU examination NOS |
Depth of genitourinary examination |
Depth of cells in anterior chamber |
Depth of anterior chamber |
Depth of examination NOS |
Depth of examination |
Depth of examination NOS |
Depth of examination |
Depth of gastrointestinal tract examination NOS |
Depth of GIT examination |
Depth of general examination NOS |
Depth of general examination |
Depth of general examn. NOS |
Depth of general examination |
Depth of resp. examn. NOS |
Respiratory examination finding |
Depth of respiratory examination NOS |
Depth of respiratory system examination |
Derangement of meniscus, NEC |
Derangement of meniscus |
Dermal appendage removal NOS |
Removal of dermal appendage |
Dermal appendage removal NOS |
Removal of dermal appendage |
Dermatitis caused by drug AND/OR medicine taken internally |
Dermatitis caused by substance taken via oral route (disorder) |
Dermatitis caused by substance taken internally |
Dermatitis caused by substance taken via oral route (disorder) |
Dermatitis due to other specified substance taken internally |
Dermatitis caused by substance taken via oral route (disorder) |
Dermatofibroma, no International Classification of Diseases for Oncology subtype |
Dermatofibroma (morphologic abnormality) |
Dermatoses NOS |
Disorder of skin (disorder) |
Dermatoses NOS |
Disorder of skin (disorder) |
Dermatosis attributable to coumarin anticoagulant |
Dermatosis caused by coumarin (disorder) |